A detailed history of Bard Financial Services, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Bard Financial Services, Inc. holds 61,935 shares of ABT stock, worth $7.05 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares
61,935
Previous 62,285 0.56%
Holding current value
$7.05 Million
Previous $7.08 Million 9.1%
% of portfolio
0.67%
Previous 0.76%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 09, 2024

SELL
$100.73 - $112.44 $35,255 - $39,354
-350 Reduced 0.56%
61,935 $6.44 Million
Q1 2024

May 06, 2024

SELL
$109.52 - $120.96 $248,610 - $274,579
-2,270 Reduced 3.52%
62,285 $7.08 Million
Q4 2023

Feb 09, 2024

BUY
$90.19 - $110.4 $159,185 - $194,856
1,765 Added 2.81%
64,555 $7.11 Million
Q3 2023

Oct 16, 2023

SELL
$95.53 - $114.62 $58,273 - $69,918
-610 Reduced 0.96%
62,790 $6.08 Million
Q2 2023

Jul 11, 2023

SELL
$100.78 - $112.29 $75,585 - $84,217
-750 Reduced 1.17%
63,400 $6.91 Million
Q4 2022

Jan 25, 2023

SELL
$95.06 - $111.52 $109,319 - $128,248
-1,150 Reduced 1.76%
64,150 $7.04 Million
Q3 2022

Oct 26, 2022

SELL
$96.76 - $112.03 $33,866 - $39,210
-350 Reduced 0.53%
65,300 $6.32 Million
Q2 2022

Jul 06, 2022

SELL
$102.07 - $123.37 $76,552 - $92,527
-750 Reduced 1.13%
65,650 $7.31 Million
Q1 2022

Apr 13, 2022

SELL
$114.02 - $139.04 $42,757 - $52,140
-375 Reduced 0.56%
66,400 $7.86 Million
Q3 2021

Oct 15, 2021

SELL
$116.66 - $129.06 $145,825 - $161,325
-1,250 Reduced 1.84%
66,775 $7.89 Million
Q1 2021

May 14, 2021

SELL
$108.84 - $128.23 $416,313 - $490,479
-3,825 Reduced 5.32%
68,025 $8.15 Million
Q4 2020

Mar 26, 2021

BUY
$105.0 - $114.42 $7.54 Million - $8.22 Million
71,850 New
71,850 $7.87 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Bard Financial Services, Inc. Portfolio

Follow Bard Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bard Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bard Financial Services, Inc. with notifications on news.